Omios Biologics Revenue

Biotechnology Research • Alameda, California, United States • 1-10 Employees

Omios Biologics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Omios Biologics

Anand Pai

Chief Technology Officer and Head of Platform

Company overview

Headquarters	Alameda, California, United States
NAICS	541714
Keywords	Gene Delivery, Cancer Vaccine, Cancer Surveillance, Immunogenic Cell Death, Oncolytic Virus Immunotherapy, Innate Immune Response, Oncolytic Vaccine, Systemic Delivery
Founded	2021
Employees	1-10

Omios Biologics Email Formats

Omios Biologics uses 1 email format. The most common is {first name} (e.g., john@omiosbio.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@omiosbio.com	100%

About Omios Biologics

Omios Bio is developing next-generation oncolytic virus therapy to treat solid tumors. Cancer is a complex disease that requires complex therapies. Our patented platform technology uses a novel vaccinia virus to target cancer cell mutations in cell death programs offering exceptional cancer selectivity, and maximum cancer cell destruction. Omios OV therapy overcomes limitations of current therapies by directly reaching metastases in a selective way, have an improved tolerability, no resistance, prevent relapse, and offer a durable effect. With a strong team, proven technology, and a large market opportunity, Omios is poised to revolutionize cancer treatment.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Omios Biologics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Omios Biologics has never raised funding before.

Frequently asked questions

Omios Biologics is located in Alameda, California, US.

Omios Biologics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Omios Biologics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Omios Biologics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Omios Biologics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Omios Biologics

Anand Pai

Chief Technology Officer and Head of Platform

4.8

40,000 users